Kristel L. Schothorst

Suggest Changes
Learn More
PURPOSE To compare the efficacy and safety of doxorubicin and docetaxel (AT) with fluorouracil, doxorubicin, and cyclophosphamide (FAC) as first-line chemotherapy for metastatic breast cancer (MBC).(More)
  • 1